As a conclusion, we chose to explore the potential of combined quantitative expression profiling of some main markers of T cell activation and differentiation, IFN-γ, IL-17, and IL-4 mRNA, to discriminate between active TB and LTBI in clinical patient groups. The gene discussed is IFNG; the disease is tuberculosis.